Table 4.
Changes in BMI and % body fat for MXR and placebo groups combined.
| Treatment | Baseline mean (SD) |
6 months mean (SD) |
12 months mean (SD) |
Tx P value |
Time P value |
Tx ∗ time P value |
|
|---|---|---|---|---|---|---|---|
| BMI | MXR | 32.95 (5.54) | 32.07 (5.72) | 32.39 (5.65) | 0.98 | 0.04 | 0.01 |
| Placebo | 32.06 (5.67) | 32.04 (5.40) | 33.36 (5.66) | ||||
|
| |||||||
| BMI z | MXR | 2.22 (0.37) | 2.08 (0.48) | 2.05 (0.49) | 0.95 | 0.001 | 0.01 |
| Placebo | 2.12 (0.39) | 2.08 (0.38) | 2.17 (0.40) | ||||
|
| |||||||
| % over BMI | MXR | 74.08 (27.84) | 67.33 (29.44) | 66.19 (29.46) | 0.85 | 0.0004 | 0.02 |
| Placebo | 68.11 (28.55) | 65.57 (27.27) | 71.13 (29.77) | ||||
|
| |||||||
| % body fat | MXR | 45.81 (5.03) | 42.65 (7.13) | 43.47 (6.17) | 0.75 | <0.0001 | 0.01 |
| Placebo | 44.57 (5.11) | 44.39 (5.23) | 44.80 (4.56) | ||||